BERGEN BRUNSWIG APPOINTS MARKETING CHIEF TO DRIVE NEW STRATEGIC FOCUS.

ORANGE, Calif.--(BUSINESS WIRE)--May 23, 1996--Bergen Brunswig Drug Company, a subsidiary of Bergen Brunswig Corporation (NYSE:BBC), announces the appointment of David Neu as its new executive vice president of marketing. Mr. Neu, previously Bergen's vice president of retail sales and systems, fills a key slot created to bridge together Bergen's retail and managed care marketing efforts.

"David's customer focus, knowledge of our industry, and experience with Bergen Brunswig differentiate him as the right person for this key position," explained Donald R. Roden, Bergen's President and Chief Operating Officer. "David has demonstrated his creative ability to tie together our customers and suppliers using innovative marketing and systems technology. Leading a strategic endeavor to focus and expand the Company's marketing competencies, David will be responsible for the development of programs and marketing initiatives to reduce our customers costs, increase their profits and increase our market share."

Mr. Neu started his pharmaceutical distribution career in 1982 with Los Angeles Drug Co., which was later acquired by Bergen Brunswig in 1986. During his tenure with Bergen Brunswig, Mr. Neu has risen through the organization holding various management positions at the division, region and corporate levels. Mr. Neu presently serves his industry as a member of the National Wholesale Druggists' Association's (NWDA) retail marketing committee and the Food Marketing Institute's (FMI) pharmacy planning committee. In addition, he recently completed his term as a member of the National Association of Chain Drug Stores' (NACDS) distribution & logistics committee.

Bergen Brunswig Corporation, with national distribution of both pharmaceuticals and medical-surgical supplies, serves its customer base - chain and independent pharmacies, hospitals, HMOs, nursing homes, clinics, and physician groups - with innovative logistics management programs that help them grow efficiently and improve the cost effectiveness of their operations and further support their focus on patient/consumer care. Bergen Brunswig Corporation's operating teams include Bergen Brunswig Drug Company, Durr Medical, IntePlex(tm), Alternate Site Distributors, and Good Neighbor Pharmacy(r).

Bergen Brunswig news releases are available at no charge through the Company's Faxline. To receive a directory of available releases, call [phone] and follow the voice-prompt instructions.

CONTACT: Lisa Riordan

Director, Investor Relations 

[phone]